Opportunity Information: Apply for PA 18 161

The National Institutes of Health (NIH) funding opportunity announcement PA 18 161, titled "Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R21 Clinical Trial Optional)," is a discretionary grant program that supports early-stage, exploratory research on symptom management for people living with long-term HIV, particularly older adults who are increasingly affected by additional health problems beyond traditional AIDS-defining illnesses. It uses the R21 mechanism, which is designed for innovative, developmental projects that can generate preliminary data, test new concepts, and lay the groundwork for larger future studies. Clinical trials are optional, meaning applicants can propose either non-trial research (such as intervention development, adaptation, feasibility work, or observational and methodological studies) or a clinical trial if the aims require testing an intervention in human participants.

The core focus is on improving how symptoms are prevented, identified, and managed when HIV coexists with other conditions, especially HIV-associated Non-AIDS conditions (often referred to as HANA) and other comorbidities. In practical terms, the opportunity is geared toward research that recognizes that many people with prolonged HIV infection experience complex symptom burdens tied to aging, chronic inflammation, long-term antiretroviral therapy, and common comorbid diseases. Projects are expected to explore strategies that are not only scientifically sound and innovative, but also cost-effective and realistic to implement in clinical or community settings. The emphasis on cost-effectiveness signals an interest in approaches that can be scaled, sustained, and integrated into real-world care, rather than solutions that only work in highly resourced research environments.

The type of work encouraged under this FOA includes developing new symptom-management interventions, adapting existing interventions for the needs of older adults with HIV, and testing promising strategies for feasibility, acceptability, and early signals of benefit. This can include approaches that address symptom clusters (for example, fatigue, pain, sleep disturbance, depression, and cognitive complaints that may occur together), strategies to improve symptom detection and monitoring (including technology-enabled screening or patient-reported outcomes), and care models that coordinate symptom management across multiple comorbid conditions. Because comorbidities in older adults with HIV can span cardiovascular disease, metabolic disorders, neurocognitive issues, liver and kidney disease, mental health conditions, and other chronic illnesses, proposals can reasonably target the intersections where HIV and these conditions compound symptom burden, reduce functioning, and increase healthcare utilization.

In terms of eligibility, the program is broadly open to many organization types, reflecting NIH's intent to encourage diverse applicants and settings. Eligible applicants include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized); tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses. The FOA also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions; Asian American, Native American, and Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); eligible federal agencies; faith-based or community-based organizations; regional organizations; U.S. territories or possessions; and non-domestic (non-U.S.) entities, meaning foreign organizations may apply where appropriate. This broad eligibility aligns with the real-world nature of symptom management research, which often benefits from partnerships among academic centers, community clinics, public health agencies, and community-based organizations.

The funding details included in the source indicate an award ceiling of $200,000, and the funding activity is categorized under education and health with CFDA number 93.361. While the listing notes an original closing date of January 7, 2020, the summary value of the FOA is in its purpose and scope: supporting innovative, preliminary symptom-management research for older adults living long-term with HIV and multiple comorbidities, with an explicit push toward interventions and strategies that can be delivered efficiently and affordably in the settings where people actually receive care.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R21 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.361.
  • This funding opportunity was created on 2017-11-07.
  • Applicants must submit their applications by 2020-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $200,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PA 18 161

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

FAQs: NIH PA-18-161 - Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R21 Clinical Trial Optional)

What is the title and identifier of this NIH funding opportunity?

The funding opportunity announcement (FOA) is NIH PA-18-161, titled "Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R21 Clinical Trial Optional)."

What is the main purpose of PA-18-161?

This FOA supports early-stage, exploratory research focused on improving how symptoms are prevented, identified, and managed for people living with long-term HIV who also have comorbid conditions. The emphasis is especially strong for older adults, who increasingly experience additional health problems beyond traditional AIDS-defining illnesses.

What type of grant mechanism does this opportunity use?

This FOA uses the NIH R21 mechanism. R21 awards are intended for innovative, developmental projects that can generate preliminary data, test new concepts, and help build a foundation for larger future studies.

Are clinical trials required under this FOA?

No. Clinical trials are optional. Applicants may propose either non-trial research (for example, intervention development or adaptation, feasibility work, observational studies, or methodological studies) or include a clinical trial if testing an intervention in human participants is needed to meet the project aims.

Who is the primary population of interest for this funding opportunity?

The FOA is geared toward people living with long-term HIV, with a particular focus on older adults who are experiencing comorbid conditions and complex symptom burdens.

What kinds of comorbid conditions are in scope?

The FOA highlights HIV-associated Non-AIDS conditions (HANA) and other comorbidities. Examples mentioned include cardiovascular disease, metabolic disorders, neurocognitive issues, liver and kidney disease, mental health conditions, and other chronic illnesses that can interact with HIV and increase symptom burden.

What symptom-related issues does NIH want projects to address?

Projects are expected to explore strategies that improve symptom prevention, symptom identification (detection), and symptom management when HIV coexists with other conditions. The FOA recognizes that long-term HIV infection can involve complex symptom burdens linked to aging, chronic inflammation, long-term antiretroviral therapy, and common comorbid diseases.

Does this FOA support work on symptom clusters rather than single symptoms?

Yes. The FOA encourages approaches that address symptom clusters, including examples such as fatigue, pain, sleep disturbance, depression, and cognitive complaints that may occur together.

What kinds of research activities are encouraged?

Encouraged activities include developing new symptom-management interventions, adapting existing interventions to better fit older adults living with HIV, and testing promising strategies for feasibility, acceptability, and early signals of benefit. The FOA also supports work that improves symptom detection and monitoring, including technology-enabled screening or patient-reported outcomes, and care models that coordinate symptom management across multiple comorbid conditions.

Does the FOA emphasize real-world implementation?

Yes. Projects are expected to propose strategies that are cost-effective and realistic to implement in clinical or community settings. The emphasis on cost-effectiveness reflects interest in approaches that can be scaled, sustained, and integrated into real-world care, rather than relying on highly resourced research-only environments.

Can proposals focus on technology-enabled symptom screening or monitoring?

Yes. The FOA explicitly mentions strategies to improve symptom detection and monitoring, including technology-enabled screening and patient-reported outcomes.

Can proposals focus on care models that coordinate symptom management across conditions?

Yes. Care models that coordinate symptom management across multiple comorbid conditions are included among the types of approaches encouraged under this FOA.

Why is older age and long-term HIV specifically emphasized?

The FOA notes that many people with prolonged HIV infection, particularly older adults, experience complex symptom burdens tied to aging, chronic inflammation, long-term antiretroviral therapy, and common comorbid diseases, making symptom management more complicated and increasingly important.

What organizations are eligible to apply?

Eligibility is broad and includes many types of organizations, such as state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses.

Are minority-serving institutions and community-based organizations eligible?

Yes. The FOA explicitly highlights eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions; AANAPISIs; Hispanic-serving Institutions; HBCUs; TCCUs; faith-based or community-based organizations; and regional organizations.

Can non-U.S. (foreign) organizations apply?

Yes. The FOA includes non-domestic (non-U.S.) entities among eligible applicants, indicating that foreign organizations may apply where appropriate.

Are U.S. territories or possessions included in eligible applicant types?

Yes. U.S. territories or possessions are explicitly listed among eligible applicant categories.

What is the award ceiling mentioned for this opportunity?

The funding details provided indicate an award ceiling of $200,000.

What is the CFDA number associated with this funding activity?

The CFDA number provided is 93.361, and the funding activity is categorized under education and health.

What closing date is listed for this opportunity?

The information provided notes an original closing date of January 7, 2020.

What is the overall theme NIH is pushing in this FOA?

The central theme is innovative, early-stage symptom-management research for people living long-term with HIV and multiple comorbidities, with an explicit push toward approaches that are efficient, affordable, scalable, and suitable for delivery in the real settings where people receive care.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Exosomes: From Biogenesis and Secretion to the Early Pathogenesis of Alzheimer's Disease (R01 - Clinical Trial Not Allowed)

Previous opportunity: Functional Wellness in HIV: Maximizing the Treatment Cascade (R21 Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 18 161

 

Applicants also applied for:

Applicants who have applied for this opportunity (PA 18 161) also looked into and applied for these:

Funding Opportunity
Health Promotion Among Racial and Ethnic Minority Males (R21 Clinical Trial Optional) Apply for PA 18 162

Funding Number: PA 18 162
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Use of Technology to Enhance Patient Outcomes and Prevent Illness (R01 Clinical Trial Optional) Apply for PA 18 145

Funding Number: PA 18 145
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Self-Management Interventions and Technologies to Sustain Health and Optimize Functional Capabilities (R01 Clinical Trial Optional) Apply for PA 18 146

Funding Number: PA 18 146
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R01 Clinical Trial Optional) Apply for PA 18 143

Funding Number: PA 18 143
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Altered neuronal circuits, receptors and networks in HIV-induced Central Nervous System (CNS) dysfunction (R21- Clinical Trial Not Allowed) Apply for RFA MH 18 611

Funding Number: RFA MH 18 611
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Palliative Care Needs of Individuals with Advanced Rare Diseases and Their Family Caregivers (R01 Clinical Trial Optional) Apply for PA 18 149

Funding Number: PA 18 149
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Innovative Questions in Symptom Science and Genomics (R21 Clinical Trial Optional) Apply for PA 18 157

Funding Number: PA 18 157
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Self-Management Interventions and Technologies to Sustain Health and Optimize Functional Capabilities (R21 Clinical Trial Optional) Apply for PA 18 164

Funding Number: PA 18 164
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers (R21 Clinical Trial Optional) Apply for PA 18 167

Funding Number: PA 18 167
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Improving Individual and Family Outcomes through Continuity and Coordination of Care in Hospice (R21 Clinical Trial Optional) Apply for PA 18 166

Funding Number: PA 18 166
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 - No Independent Clinical Trials) Apply for PAR 18 349

Funding Number: PAR 18 349
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Altered neuronal circuits, receptors and networks in HIV-induced Central Nervous System (CNS) dysfunction (R01)-Clinical Trial Not Allowed Apply for RFA MH 18 610

Funding Number: RFA MH 18 610
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) Apply for PAR 18 008

Funding Number: PAR 18 008
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) Apply for PAR 18 019

Funding Number: PAR 18 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Promoting Caregiver Health Using Self-Management (R01 Clinical Trial Optional) Apply for PA 18 150

Funding Number: PA 18 150
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Chronic Condition Self-Management in Children and Adolescents (R01 Clinical Trial Optional) Apply for PA 18 151

Funding Number: PA 18 151
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Reducing Health Disparities Among Minority and Underserved Children (R01 Clinical Trial Optional) Apply for PA 18 152

Funding Number: PA 18 152
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Chronic Condition Self-Management in Children and Adolescents (R21 Clinical Trial Optional) Apply for PA 18 168

Funding Number: PA 18 168
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Reducing Health Disparities Among Minority and Underserved Children (R21 Clinical Trial Optional) Apply for PA 18 169

Funding Number: PA 18 169
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) Apply for PAR 18 064

Funding Number: PAR 18 064
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 18 161", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: